Mia's Feed
Medical News & Research

Impact of Preterm Birth on Adult Blood Pressure and Anxiety Levels

Impact of Preterm Birth on Adult Blood Pressure and Anxiety Levels

Share this article

Research links preterm birth to increased blood pressure and anxiety in adulthood. Long-term effects include metabolic and psychological risks, highlighting the need for targeted screening and care.

2 min read

Preterm birth, which affects approximately 10% of infants in the United States annually, has long been associated with immediate health challenges in newborns. However, recent research indicates that the implications of early birth extend far into adulthood, influencing both physical and mental health outcomes.

A comprehensive longitudinal study led by researchers from the University of Rhode Island tracked individuals from birth into their mid-thirties to understand these long-term effects. The study included 213 participants originally admitted to a Level III neonatal intensive care unit between 1985 and 1989. Of these, 158 were born preterm (with birth weights under 1,850 grams), and 55 were born at full term. Data collection involved clinical assessments, biospecimen analyses, imaging, and psychological evaluations at age 35.

The researchers devised a medical risk index based on factors like birth weight, gestational age, duration of oxygen therapy, and neurological and medical complications endured during early life. Findings revealed that each point increase in the early-life medical risk score was linked to a significant rise in adverse health markers in adulthood.

Specifically, higher early medical risk correlated with a 7-point increase in systolic blood pressure, a decrease of 13 mg/dL in HDL cholesterol, and a rise of 54 mg/dL in triglycerides. Additionally, individuals with higher early life risk showed increased abdominal fat accumulation, lower bone mineral density, and heightened internalizing issues such as anxiety and depression.

Interestingly, no significant associations were found with diastolic blood pressure, LDL cholesterol, hemoglobin A1c, or inflammatory markers. Socioeconomic status during childhood and social protection did not significantly impact these health outcomes; however, higher socioeconomic status was associated with lower levels of IL-6, an inflammatory marker.

The study underscores that the severity of complications at birth due to preterm delivery can have enduring effects, impacting mental health and cardiovascular risk factors decades later. Given the lack of clinical guidelines for routine adult screening of those born preterm, healthcare providers are urged to consider early birth history as an essential component of lifelong risk assessments. Implementing targeted monitoring and preventive care strategies for this population could mitigate long-term health vulnerabilities.

Source: https://medicalxpress.com/news/2025-07-preterm-birth-linked-higher-blood.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Impact of Alcohol on Embryonic Gene Function and Development

New research reveals that alcohol exposure during early pregnancy can significantly alter gene function and cellular development in embryos, increasing the risk of neurodevelopmental disorders and fetal damage.

New Insights into Mitochondrial Dysfunction's Role in Alzheimer’s Disease Progression and Therapy

Recent Mayo Clinic research highlights mitochondrial complex I dysfunction as a key factor in Alzheimer's disease, opening new paths for early intervention and personalized treatment strategies.

Antiviral Therapy Shows No Effect on Early-Stage Alzheimer's Progression

A groundbreaking clinical trial shows that antiviral medication does not slow the progression of early-stage Alzheimer's disease, challenging previous hypotheses linking herpes infections to the condition.

Innovative Innate Immune Checkpoint Inhibitor Demonstrates Potential Against Solid Tumors in Animal Studies

A groundbreaking innate immune checkpoint inhibitor shows promising results against solid tumors in preclinical rodent models, opening new possibilities in cancer immunotherapy.